There is no shortage of research investigating the effectiveness of the Breast Imaging Reporting and Data System (BI-RADS) category 3 in mammography, but what’s less understood is why some women complete follow-up recommendations while many do not.

Breast cancer phenotype can influence MRI’s ability to evaluate the effectiveness of chemotherapy, according to a study published Oct. 4 in the European Journal of Radiology. But which specific tumor subtypes have the greatest impact on the modality’s performance?

A new magnetic “seed” technology can help radiologists localize breast lesions and offers benefits over traditional wire-guided localization (WGL), reported authors of a study published Oct. 3 in the European Journal of Radiology.

The National Cancer Institute—part of the National Institutes of Health (NIH)—has awarded researchers at the University of Arizona Health Sciences $3.6 million to investigate a new imaging-based method to detect breast cancer.

The Radiological Society of North America (RSNA) has published their first issue of Radiology: Imaging Cancer, a new online journal dedicated to the latest in cancer imaging.

“Knowing that the cancer yield of screening US is similar after DBT versus DM may help inform clinical practice, because questions abound about whether DBT is sufficient screening for women with dense breast tissue," wrote authors of a new study published in the American Journal of Roentgenology.

Screening mammography was shown to identify more cancers than the average detection rate in men at a high risk for breast cancer, according to a new study published in Radiology. The tool may save lives by detecting cancers earlier than other screening methods.

The American College of Radiology (ACR) announced the acquisition of the My CT Colonography center online locator, a tool to help patients find exam centers quickly and easily.

A new machine learning approach can predict the negative side effects of radiation treatment in patients with head and neck cancers. The findings, presented at the American Society for Radiation Oncology (ASTRO) annual meeting, can help select patients who might need a more tailored care approach.

High-dose, targeted radiation can be a safe and effective option for men with oligometastatic prostate cancer, according to findings presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO) in Chicago.

Exposure to diagnostic low-dose ionizing radiation is associated with an increased risk of developing cancer among pediatric patients, according to a recent study published in JAMA Network Open.

The American Society for Radiation Oncology (ASTRO) has updated its recommendations for using radiation therapy to treat patients with diagnosed pancreatic cancer.